StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Leqvio Global Growth in USD by Quarter

Leqvio Global Growth in USD (% USD) (%)

QuarterlyAnnual

Novartis Leqvio Global Growth in USD: 64.0% in Q3 2026, up 8.0 pts from a year earlier.

Latest, Q3 2026
64.0%
Period ended Sep 30, 2026
Change on a year earlier
+8.0 pts
56.0% in Q3 2025
History
14 quarters
Since Q2 2023
Sources
14
Documents cited below

Where the Q3 2026 figure comes from

“|| Leqvio | 506 | 308 | 64 | 63”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLeqvio Global Growth in USD (% USD) (%)Year on yearSource
Q3 2026Sep 30, 202664.0%+8.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202661.0%-3.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 202676.0%+6.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202550.0%-31.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 202556.0%-64.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 202564.0%-69.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 202570.0%-66.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 202481.0%-112.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 2024120.0%-45.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 2024133.0%-122.0 ptsNovartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 2024136.0%–Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 2023193.0%–Novartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 2023165.0%–Novartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 2023255.0%–Novartis Form 6-K (0001370368-23-000059) ↗

Cite this data

StockData. (2026). Novartis Leqvio Global Growth in USD (%), quarterly Q2 2023–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-leqvio-yoy-usd-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.